Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -69.75% is 10% above its 3-year average of -77.53%, near the high end of its 3-year range (-283.93%–-50.20%).
4.71% above its 12-month average of -73.20%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -79.90%.
OPERATING MARGIN
-69.75%
OPERATING MARGIN AVG TTM
-73.20%
OPERATING MARGIN AVG 3Y
-77.53%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4.71%
CURRENT VS 3Y AVG
+10.03%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Beta Bionics, Inc.
Market Cap
$840.62M
Operating Margin
-69.75%
TTM Avg
-73.20%
3Y Avg
-77.53%
5Y Avg
N/A
Market Cap
$840.79M
Operating Margin
-30.67%
TTM Avg
-52.06%
3Y Avg
-18.41%
5Y Avg
7.25%
Market Cap
$842.23M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$838.63M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$838.46M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
Market Cap
$849.50M
Operating Margin
-348.46%
TTM Avg
-328.22%
3Y Avg
-265.67%
5Y Avg
-226.03%
Market Cap
$857.86M
Operating Margin
-8.31%
TTM Avg
-16.09%
3Y Avg
-30.50%
5Y Avg
-38.64%
Market Cap
$860.77M
Operating Margin
-174.65%
TTM Avg
-105.11%
3Y Avg
-66.40%
5Y Avg
-66.40%
Market Cap
$815.54M
Operating Margin
-7.86%
TTM Avg
-9.22%
3Y Avg
-47.88%
5Y Avg
-486.53%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $840.62M | -69.75% | -73.20% | -77.53% | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $840.79M | -30.67% | -52.06% | -18.41% | 7.25% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $842.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alumis Inc. (ALMS)vs › | $838.63M | -1776.32% | -888.16% | -444.08% | -444.08% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $838.46M | -43.83% | -75.55% | -37.77% | -25.18% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | -348.46% | -328.22% | -265.67% | -226.03% |
| SI-BONE, Inc. (SIBN)vs › | $857.86M | -8.31% | -16.09% | -30.50% | -38.64% |
| SL Science Holding Ltd (SLBT)vs › | $860.77M | -174.65% | -105.11% | -66.40% | -66.40% |
| Ardelyx, Inc. (ARDX)vs › | $815.54M | -7.86% | -9.22% | -47.88% | -486.53% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $866.82M | 42.63% | 28.06% | -1.90% | -7.11% |
Gross Margin
58.3%
Operating Margin
-69.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -79.90% |
| 2026-03-31 | -87.86% |
| 2025-12-31 | -50.20% |
| 2025-09-30 | -62.54% |
| 2025-06-30 | -85.52% |
| 2025-03-31 | -105.69% |
| 2024-12-31 | -63.78% |
| 2024-09-30 | -65.71% |
| 2024-06-30 | -78.32% |
| 2024-03-31 | -73.09% |
| 2023-12-31 | -100.20% |
| 2023-09-30 | -283.93% |
